Share
bendectin and birth defects: the challenges of mass toxic substances litigation (in English)
Michael D. Green
(Author)
·
University of Pennsylvania Press
· Paperback
bendectin and birth defects: the challenges of mass toxic substances litigation (in English) - Green, Michael D.
$ 31.54
$ 39.95
You save: $ 8.41
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My WishlistsIt will be shipped from our warehouse between
Wednesday, May 29 and
Thursday, May 30.
You will receive it anywhere in United States between 1 and 3 business days after shipment.
Synopsis "bendectin and birth defects: the challenges of mass toxic substances litigation (in English)"
Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabilities would result in precedent-setting litigation. Before it was over, the Benedictin litigation would involve 2,000 claimants over a fifteen-year period. Michael D. Green offers a comprehensive overview of the Benedictin case and highlights many of the key issues in mass toxic substances litigation, comparing individual and collective forms of litigation, and illustrating the misunderstandings between scientists and lawyers about the role of science in providing evidence for the legal system.
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.
✓ Producto agregado correctamente al carro, Ir a Pagar.
